LMAT vs UFPT
As of Sep 20, 2026, Lemaitre Vascular (LMAT) scores 3.5/10 and UFP Technologies (UFPT) 7.2/10 on AlphaStocks' five-model composite, so UFPT scores higher. LMAT trades 17% above its model fair value; UFPT trades 26% above its model fair value.
LMAT
LEMAITRE VASCULAR INC
3.5
Weak
$78.88
UFPT
UFP TECHNOLOGIES INC
7.2
Consider Buy
$276.28
LMAT vs UFPT: Which is the Better Investment?
LEMAITRE VASCULAR INC (LMAT) scores 3.5/10 while UFP TECHNOLOGIES INC (UFPT) scores 7.2/10 on AlphaStocks' composite model. UFP TECHNOLOGIES INC has the higher composite rating of Consider Buy. On a P/E basis, LEMAITRE VASCULAR INC trades at 31.3x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | LMAT | UFPT |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 3.5/10 | 7.2/10▲ |
| Rating | Weak | Consider Buy▲ |
| Price | $78.88 | $276.28 |
| P/E Ratio | 31.3▲ | 31.6 |
| ROE | 14.9% | 16.5%▲ |
| Market Cap | $2B | $2B |
| Fair Value | $67.42 | $219.16 |
| Dividend Yield | 0.8% | — |
| Sector Rank | #148 of 168 | #12 of 168▲ |
| Model Verdicts | ||
| Piotroski | Attractive | Strong▲ |
| Buffett | Attractive | Attractive |
| Graham | Neutral | Neutral |
| Lynch | Neutral | Neutral |
| Greenblatt | Caution | Neutral▲ |
Related comparisons
LMAT vs UFPT: Which Stock Scores Higher?
LEMAITRE VASCULAR INC (LMAT) and UFP TECHNOLOGIES INC (UFPT) are both in the Health Care sector. UFPT currently leads with a composite score of 7.2/10 (Consider Buy) compared to LMAT's 3.5/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer